Role of the sympathetic nervous system during the development of obesity-induced hypertension in rabbits

American Journal of Hypertension

Volumn 13, Issue 5 II SUPPL., 2000, Pages 556-559

  Antic, Vladan ^a   Kiener Belforti, Francesca ^a   Tempini, Aldo ^a   Van Vliet, Bruce N ^b   Montani, Jean Pierre ^a  

^a UNIVERSITY OF FRIBOURG   (Switzerland)

^b MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Blockade; High fat diet; Hypertension; Obesity; Rabbits; Sympathetic

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PROPRANOLOL; TERAZOSIN;

ADRENERGIC RECEPTOR BLOCKING; ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MONITORING; BODY WEIGHT; CONTROLLED STUDY; HEART RATE; HYPERTENSION; LIPID DIET; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; RABBIT; TELEMETRY; WEIGHT GAIN;

ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; DIETARY FATS; GLOMERULAR FILTRATION RATE; HEART RATE; HYPERTENSION; INJECTIONS, INTRAVENOUS; KIDNEY; MALE; OBESITY; PHENYLEPHRINE; PRAZOSIN; PROPRANOLOL; RABBITS; SODIUM; SYMPATHETIC NERVOUS SYSTEM; SYMPATHOMIMETICS; TELEMETRY;

EID: 0034070101     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0895-7061(99)00267-8     Document Type: Article

References (17)

1. Sowers JR, Nyby M, Stern N, Beck F, Baron S, Catania R, Vlachis N: Blood pressure and hormonal changes associated with weight reduction in the obese. Hypertension 1982;4:686-691.
2. Landsberg L, Young JB: Fasting, feeding and regulation of the sympathetic nervous system activity. N Engl J Med 1978;298:1295-1301.
3. Scherrer U, Randin D, Tappy L, Vollenweider P, Jequier E, Nicod P: Body fat and sympathetic nerve activity in healthy subjects. Circulation 1994;89:2634-2640.
4. Hall JE, Van Vliet BN, Garrity CA, Connell RD, Brands MW: Role of increased adrenergic activity in obesity-induced hypertension (abst). Circulation 1992;86(suppl I):I-541.
5. Rocchini AP, Mao HZ, Babu K, Marker P, Rocchini AJ: Clonidine prevents insulin resistance and hypertension in obese dogs. Hypertension 1999;33[part II]:548-553.
6. Carroll JF, Dwyer TM, Grady AW, Reinhart GA, Montani JP, Cockrell K, Meydrech EF, Mizelle HL: Hypertension, cardiac hypertrophy, and neurohumoral activity in a new animal model of obesity. Am J Physiol 1996;271:H373-378.
7. Carroll JF, Summers RL, Dzielak DJ, Cockrell K, Montani JP, Mizelle HL: Diastolic compliance is reduced in obese rabbits. Hypertension 1999;33:811-815.
8. Antic V, Tempini A, Montani JP: Serial changes in cardiovascular and renal function of rabbits ingesting a high-fat, high-calorie diet. Am J Hypertens 1999;12:826-829.
9. Montani JP, Mizelle HL, Van Vliet BN, Adair TH: Advantages of continuous measurement of cardiac output 24 h a day. Am J Physiol 1995;269:H696-H703.
10. Grace SA, Munday KA, Noble AR: Sodium, potassium and water metabolism in the rabbit: the effect of sodium depletion and repletion. J Physiol 1979;292:407-420.
11. Van Vliet BN, Hall JE, Mizelle HL, Montani JP, Smith MJ Jr: Reduced parasympathetic control of heart rate in obese dogs. Am J Physiol 1995;269:H629-H637.
12. Hall JE, Brands MW, Dixon WN, Smith MJ: Obesity-induced hypertension: renal function and systemic hemodynamics. Hypertension 1993;22:292-299.
13. Van Vliet BN, Lohmeier TE, Mizelle HL, Hall JE: The kidney, in Bennet T, Gardiner S (eds): Nervous Control of Blood Vessels. The Autonomic Nervous System, Vol 8. London, Harwood Academic Publishers, 1996, pp 371-433.
14. Kassab S, Kato T, Wilkins FC, Chen R, Hall JE, Granger JP: Renal denervation attenuates the sodium retention and hypertension associated with obesity. Hypertension 1995;25:893-897.
15. Shek EW, Brands MW, Hall JE: Chronic leptin infusion increases arterial pressure. Hypertension 1998;31:409-414.
16. Haynes WG, Sivitz WI, Morgan DA, Walsh SA, Mark AL: Sympathetic and cardiorenal actions of leptin. Hypertension 1997;30:619-623.
17. Shek EW, Kim PK, Hall JE: Adrenergic blockade prevents leptin-induced hypertension (abst). FASEB J 1999;13:A456.